Neural tube defect is a group of birth conditions that affect the brain, spine, or spinal cord. These features are present at birth and can range from mild to severe. Babies with a neural tube defect may have weakness in the legs, fluid on the brain, or openings in the back. Outcomes vary, and some forms can be life‑threatening without prompt care, but many children live well with treatment. Care often includes surgery soon after birth, ongoing therapies, and folic acid planning for future pregnancies.
Overview
Neural tube defectSymptoms
Neural tube defect features range by type. Prenatal scans may show an open spine or skull, a fluid-filled sac, or severe brain underdevelopment. At birth, babies may have a back opening, leg weakness, or head swelling from fluid buildup.
Outlook and prognosis
Many living with a neural tube defect can lead active, fulfilling lives with timely care, early surgery when needed, and ongoing support. Outcomes vary by type and severity, from minimal impact to mobility, bladder, or learning challenges. Regular check-ins help prevent complications and maintain independence.
Causes and risk factors
Neural tube defects arise from a mix of genetic susceptibility and early‑pregnancy development factors. Low folate, preexisting diabetes, obesity, certain anti‑seizure medicines, and high fever/sauna heat raise risk. Family history and some pregnancies (e.g., twins) increase chances.
Genetic influences
Genetics play a meaningful role in neural tube defects, but they’re only part of the picture. Variations in several genes can raise risk, especially with low folate, certain medicines, or diabetes. Most cases are multifactorial, not strictly inherited.
Diagnosis
Diagnosis of neural tube defect often starts before birth with ultrasound and maternal blood screening. After delivery, clinical features are clear, with MRI or CT to define extent. Genetic tests may be used when syndromes or recurrence risk are suspected.
Treatment and drugs
Treatment for a neural tube defect depends on the type, location, and severity. Care often includes early surgery to protect the spinal cord or brain, infection prevention, bladder and bowel support, and physical therapy, followed by ongoing neurology and rehabilitation follow-up.
Symptoms
Families often first learn about a neural tube defect during pregnancy screening or at birth. Some early features of neural tube defect can be seen on ultrasound or a blood test, while others are noticed right away in a newborn. Signs vary from person to person and can change over time. Day to day, the impact depends on which parts of the spine or skull are involved.
Ultrasound may show an opening in the spine or an unusual head or skull shape. A pregnancy blood test may suggest a neural tube defect and prompt closer follow-up.
A gap along the spine may be open or covered by a thin layer of skin. You might see a soft sac filled with fluid on the back.
A small dimple, patch of hair, or birthmark over the spine can signal a hidden spinal opening. These are often subtle and are worth checking.
The legs may be weak, numb, or hard to move. This can affect crawling, standing, or walking.
How people usually first notice Neural tube defect?
Many parents and clinicians first notice a neural tube defect during routine prenatal care, when an ultrasound shows findings like an open spine (spina bifida) or a skull/brain development problem (anencephaly), often after a blood test shows high alpha‑fetoprotein levels. Sometimes the first signs of neural tube defect appear at birth, such as a visible opening or sac on a baby’s back, or changes in head shape and muscle tone that prompt urgent evaluation. In milder cases, how neural tube defect is first noticed may be later in infancy when a skin dimple, tuft of hair, or small fatty lump over the lower spine leads to imaging and diagnosis.
Types of Neural tube defect
Neural tube defect has several well-recognized types, and each tends to affect daily life differently. Some types mainly impact the spine and leg strength; others involve the skull and brain, which can affect development, learning, and movement. Not everyone will experience every type. When people talk about types of neural tube defect, they usually mean the specific pattern of where the tube didn’t close and how much tissue is involved.
Spina bifida occulta
The most common and mildest form with a small gap in the spine, usually covered by skin. Many people have no symptoms and discover it incidentally on an X-ray. Some notice a dimple, tuft of hair, or small birthmark over the lower back.
Meningocele
A fluid-filled sac pushes through a gap in the spine, but the spinal cord stays in place. Symptoms can be mild, and some people have few or no nerve problems. Surgery often repairs the sac to protect the nerves.
Myelomeningocele
The most severe spinal form with spinal cord and nerves bulging into a sac through the back. This can cause leg weakness or paralysis, bladder and bowel issues, and risk of infection at birth. Many need early surgery and long-term mobility and continence support.
Anencephaly
The upper neural tube doesn’t close, leading to missing parts of the brain and skull. This condition is not compatible with long-term survival. Care focuses on comfort and family support.
Encephalocele
A sac containing brain tissue and fluid bulges through an opening in the skull. Effects vary by size and location, from seizures and movement issues to learning differences. Treatment usually involves neurosurgery and developmental supports.
What genetics can tell you about symptoms
Some neural tube defects are linked to variants in genes that help the early brain and spine close, such as MTHFR, VANGL, and CELSR genes. These changes can raise the chance of spinal openings (spina bifida) or missing skull/brain tissue (anencephaly).
Causes and risk factors
Neural tube defects start when the early brain and spine do not close fully in the first month of pregnancy. Low folate around conception is a key driver of this risk. Doctors distinguish between risk factors you can change and those you can’t. Changeable risk factors for Neural tube defect include low folic acid intake, poorly controlled diabetes, obesity, high fevers or hot tub use, and some anti-seizure medicines. Non-changeable risks include a prior pregnancy with a neural tube defect, family history, and genetic differences that influence folate metabolism.
Environmental and biological risk factors
Risk for a neural tube defect can be shaped by both body-based factors and what you’re exposed to around early pregnancy. Doctors often group risks into internal (biological) and external (environmental). Below are environmental risk factors for neural tube defect and related biological influences that research has linked to higher likelihood, especially in the first few weeks when the neural tube forms.
Diabetes present before pregnancy, especially when blood sugar is high around conception, increases the chance of a neural tube defect. The risk is strongest in the earliest weeks of development.
A high body temperature in the first month of pregnancy can raise the risk of a neural tube defect. This includes fevers from infections and excessive heat from hot tubs or saunas.
Some anti-seizure medicines, especially valproate, are linked to a higher chance of a neural tube defect. Risk relates to dose and timing in very early pregnancy.
Medications that interfere with folate pathways, such as some antibiotics or chemotherapy drugs, can increase neural tube defect risk. Effects are most concerning in the first weeks after conception.
Genetic risk factors
Most cases involve a mix of inherited susceptibility and chance, rather than a single gene acting alone. This section focuses on the genetic causes of neural tube defects and how they influence recurrence in families. Risk is not destiny—it varies widely between individuals. When a neural tube defect has occurred before, doctors may discuss specific genetic factors and the likelihood of it happening again.
Previous affected pregnancy: Having had a baby with a neural tube defect raises the chance in a future pregnancy to about 2–5% (2–5 in 100). After two affected pregnancies, the chance can approach 10% (about 1 in 10). A genetics visit can tailor these numbers to your family.
Parent with NTD: When a parent lives with a neural tube defect, the chance their child will be affected is roughly 1–5% (1–5 in 100). The exact risk depends on the specific type and the broader family history. Genetic counseling can review both partners’ histories together.
Chromosome differences: Some cases occur alongside chromosome conditions such as trisomy 13 or trisomy 18. In these situations, the spine or brain finding is one feature of a broader genetic condition. Prenatal diagnostic testing can sometimes identify these differences.
Rare genetic syndromes: Certain uncommon inherited syndromes can include a neural tube defect as part of the picture. Many follow autosomal recessive inheritance, where each parent carries one silent change. In those families, the chance of recurrence can be up to 25% (1 in 4) with each pregnancy.
Folate pathway variants: Common changes in genes that process folate and related nutrients have been linked to a small increase in risk. On their own, these variants do not reliably predict who will have an affected pregnancy. Many carriers have healthy pregnancies.
Tube-formation genes: Rare changes in genes that guide early tube closure can disrupt development and lead to a neural tube defect. These variants are uncommon and may be inherited or arise for the first time in the embryo. Broader gene testing may be considered when multiple features are present.
Polygenic background: For many families, risk reflects the combined effect of many small genetic differences rather than a single gene. This helps explain why siblings can have different outcomes even with similar backgrounds. Patterns can also vary between populations.
Parental relatedness: When parents are related by blood (such as cousins), the chance of rare recessive conditions that include these defects is higher. That’s because both parents are more likely to carry the same uncommon gene change. A genetics specialist can discuss carrier testing options.
Lifestyle risk factors
Neural tube defects are congenital conditions; lifestyle habits do not cause them but can influence risk in the weeks just before and after conception. Planning and daily routines around nutrition and activity can help lower that risk. This overview focuses on lifestyle risk factors for neural tube defect and how lifestyle affects neural tube development.
Not getting enough folic acid before conception and during early pregnancy raises the risk of neural tube defects. Consistent folate intake supports proper neural tube closure.
Skipping a daily folic acid supplement around conception leaves a critical gap during the short window when the neural tube forms. A simple daily pill habit improves protection.
Inadequate vitamin B12 can increase neural tube defect risk even when folate intake is adequate. Including B12-rich foods or a supplement is especially important for vegans and vegetarians.
Diets low in fortified grains, legumes, leafy greens, and dairy or eggs can reduce folate and B12 availability, elevating neural tube defect risk. A varied, nutrient-dense eating pattern supports fetal neural development.
Risk prevention
If you’re planning a pregnancy, a few steps before and during early pregnancy can lower the chance of a baby having a neural tube defect. Even if you can’t remove all risks, prevention can reduce their impact. Learning how to prevent neural tube defects starts before conception with daily folic acid and a preconception check-in. Some people need tailored plans based on health history, medicines, or a past pregnancy affected by an NTD.
Take 400 micrograms (0.4 mg) of folic acid every day starting at least 1 month before pregnancy and through the first 12 weeks. This lowers the risk of neural tube defect. Use a prenatal vitamin and choose folate‑fortified grains and cereals.
If you had a prior pregnancy with a neural tube defect, take certain anti-seizure medicines, have diabetes, or have BMI ≥30, your clinician may recommend 4 mg (4,000 micrograms) daily. Use a separate folic acid tablet plus your prenatal vitamin so you don’t get too much of other vitamins.
Aim for healthy blood sugar before conception and during early pregnancy. Good glucose control can reduce the risk of neural tube defect.
Some anti-seizure medicines and folate-blocking drugs can raise NTD risk. Never stop a prescription on your own—talk to your clinician about safer alternatives or dose changes.
Transmission
Neural tube defect is not contagious; it cannot be spread through touch, air, food, sex, or blood. It develops very early in pregnancy and usually results from a mix of inherited tendency and environmental factors, such as low folate levels, some medicines, uncontrolled diabetes, or obesity.
When discussing how neural tube defect is inherited, most cases do not follow a simple pattern: the risk is slightly higher if a parent, sibling, or a previous pregnancy was affected, and rarely it occurs as part of a specific genetic syndrome. If you’ve had one pregnancy with a neural tube defect, your care team may talk about a higher recurrence risk and steps to lower it—especially taking folic acid before conception and during early pregnancy.
When to test your genes
Neural tube defects aren’t typically detected by personal genetic tests, but targeted testing can help in specific situations. Consider genetic counseling and testing if you or a partner had a prior pregnancy affected, there’s a family history, or screening in pregnancy shows increased risk. Preconception counseling also guides folate dosing to lower risk.
Diagnosis
Diagnosis of neural tube defect usually starts before birth and focuses on spotting structural changes in the developing brain and spine. Most clues come from pregnancy screening and detailed imaging, and results are confirmed with follow‑up tests if needed. Family history is often a key part of the diagnostic conversation. After delivery, doctors look for physical features and use imaging to define the type and severity.
A detailed scan around 18–22 weeks can show openings in the spine, skull, or brain suggestive of a neural tube defect. Sonographers also look for indirect signs like fluid levels in the brain or changes in the skull shape.
A blood test that measures alpha‑fetoprotein (AFP) in the second trimester can point to an open neural tube defect when levels are higher than expected. If AFP is elevated, dates and twin status are rechecked and a targeted ultrasound is arranged.
High‑resolution ultrasound at a specialist center provides closer views of the spine, skull, and brain. This helps confirm the location and extent of a neural tube defect and guides next steps.
When ultrasound images are unclear or more detail is needed, MRI can map the brain and spine without radiation. MRI can clarify the type of neural tube defect and help plan delivery and early care.
Stages of Neural tube defect
Neural tube defect does not have defined progression stages. These birth differences happen early in pregnancy as the brain and spine form, so they don’t unfold over time like a condition that worsens in steps; instead, the type and severity are present from birth. Before birth, screening may include a parent’s blood test that checks protein levels, detailed ultrasound imaging, and sometimes amniocentesis; after birth, doctors confirm findings with a newborn exam and spine or brain imaging, and they look for early symptoms of neural tube defect such as leg weakness or bladder and bowel difficulties. Different tests may be suggested to help clarify the type and plan care.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many living with a neural tube defect, the outlook spans a wide range—from few day‑to‑day limitations to complex medical needs. Some babies have mild spine changes with little impact on mobility, while others face paralysis, bladder or bowel issues, learning challenges, or frequent infections. Early care can make a real difference, especially when coordinated by a team that includes neurology, urology, rehabilitation, and social support.
The outlook is not the same for everyone, but survival into adulthood is common with modern care. Risks are higher when hydrocephalus, severe paralysis, or repeated infections are present, and early surgery for the back opening and shunt placement can lower complications. When thinking about early symptoms of neural tube defect, parents may first notice leg weakness or foot positioning at birth, and later, tethered cord symptoms like back pain or changes in continence. With ongoing care, many people maintain independence in school, work, and relationships, using braces, wheelchairs, or continence programs as needed.
In terms of life expectancy, many children with a neural tube defect live well into adulthood; mortality is higher in the first years of life when there are serious brain or infection complications. As people age, common health issues include skin breakdown from pressure, kidney problems from bladder dysfunction, and shunt failures if hydrocephalus is present. Understanding the prognosis can guide planning and support, from accessibility at home to transition to adult care. Talk with your doctor about what your personal outlook might look like, including goals, supports, and the steps that can help you stay healthy over time.
Long-term effects
For people born with a neural tube defect, the long-term picture depends on the type (for example, spina bifida or encephalocele) and how much the brain, spinal cord, and nerves were affected. Long-term effects vary widely and can change over time. While early symptoms of neural tube defect may be noticed in infancy, many features only become clearer in school years, adolescence, or adulthood. Some live independently with supports, while others need ongoing medical care and assistive devices.
Many with a neural tube defect have leg weakness or paralysis that affects walking and balance. Some use braces, crutches, or a wheelchair as distances and terrains change.
Nerve changes can lead to urinary leakage, urinary tract infections, and constipation or stool leakage. Over time, bladder pressure and infections can affect kidney health.
Extra fluid around the brain (hydrocephalus) is common in spina bifida and may require a shunt. Shunts can work well for many years but may need revisions over time.
Many have average intelligence but differences in attention, planning, processing speed, or math. School and work tasks that require fast visual-motor skills can be harder.
How is it to live with Neural tube defect?
Living with a neural tube defect can mean navigating mobility, bladder or bowel challenges, and frequent medical visits, while still building routines that support school, work, and relationships. Many people use wheelchairs or braces, manage skin care and pressure relief, and plan their day around accessible transportation, catheterization schedules, and energy levels. Families, classmates, and coworkers often learn practical ways to help—like ensuring barrier‑free spaces and flexible timing—while also recognizing that independence and goals vary widely from person to person. With good care, adaptive equipment, and a supportive network, many find steady rhythms that allow for participation in community, education, and meaningful work.
Treatment and drugs
Treatment for a neural tube defect depends on the type, location, and severity, and care typically starts soon after birth. Babies with spina bifida often need surgery in the first days of life to close the opening in the spine, protect the nerves, and lower the risk of infection; some also need a shunt to relieve fluid buildup in the brain, along with long-term support from physical therapy, bladder and bowel care, and mobility aids. When spina bifida is detected before birth, some centers offer fetal surgery to repair the opening during pregnancy, which can reduce certain complications, though it carries risks that specialists will discuss with you. Anencephaly has no curative treatment; care focuses on comfort and family support. Treatment plans often combine several approaches, and ongoing follow-up helps address changes in movement, learning, skin care, and independence over time.
Non-drug treatment
Living with a neural tube defect can affect movement, bladder and bowel control, learning, and day-to-day independence. Care plans are tailored across life stages—from before birth to school and adulthood—so support matches current needs and goals. Non-drug treatments often lay the foundation for long-term function and independence. Plans also reflect that early symptoms of neural tube defect can range from almost none to clear challenges with walking or continence.
Specialists explain findings on scans and outline options for delivery and care. They also help plan where and when to give birth for the safest start.
In select cases, surgeons can repair an open spine before birth to protect nerves. This can reduce complications, though it carries risks for parent and baby.
Soon after birth, surgeons close the opening over the spine to protect tissues and lower infection risk. This procedure does not reverse nerve damage but helps prevent further injury.
Teams regularly check head growth and development to spot fluid buildup early. Some babies may need a shunt or other procedure, and ongoing follow-up helps keep it working well.
Your genes may have an impact on how drugs work for you
Some medicines used during pregnancy are processed differently depending on genes that affect liver enzymes, which can change drug levels and, in turn, risk to the developing neural tube. Genetic guidance can help choose safer doses or alternatives when possible.
Pharmacological treatments
Medicines play a supporting role for people living with a neural tube defect, often alongside surgery, catheters, bracing, and physical or occupational therapy. You might picture medicine as one tool among many—alongside surgery, catheters, bracing, and therapy. When early symptoms of neural tube defect are recognized in newborns, medicines can help manage bladder, bowel, pain, and muscle issues while longer-term plans are set. For families planning another pregnancy after an affected child, specific vitamins can lower the risk of recurrence.
High-dose folic acid before conception and through the first trimester can lower the chance of a future neural tube defect; many high‑risk patients are advised 4 mg (4,000 mcg) daily. Your obstetrician may suggest a prescription-strength tablet separate from a standard prenatal vitamin.
Oxybutynin, tolterodine, or solifenacin can calm overactive bladder and help protect the kidneys. They may improve continence but can cause dry mouth or constipation.
Mirabegron helps the bladder store urine better, especially if anticholinergics aren’t tolerated or don’t fully work. Blood pressure is checked because this medicine can raise it in some people.
Injections into the bladder wall can reduce spasms and leakage in neurogenic bladder. Benefits often last several months and may be repeated based on response.
Genetic influences
Neural tube defect risk is shaped by both inherited factors and the environment. For most families there’s no prior history, but having had one pregnancy affected slightly raises the chance (about 2–5%) in a future pregnancy. Family history is one of the strongest clues to a genetic influence. There isn’t one genetic cause of neural tube defect; instead, many small gene changes—especially in processes that help the body use folate—can nudge risk up or down. In a minority of cases, a neural tube defect occurs with other birth differences as part of a chromosomal or single‑gene condition, and in those families the pattern of inheritance and recurrence risk may be clearer. Because genes interact with factors like folate intake before conception, certain anti‑seizure medicines, obesity, and diabetes, genetic testing can sometimes inform risk but usually cannot predict with certainty.
Is Neural tube defect genetic?
Genetics play a meaningful role in neural tube defects, but they’re only part of the picture. Variations in several genes can raise risk, especially with low folate, certain medicines, or diabetes. Most cases are multifactorial, not strictly inherited.
Pharmacogenetics—how genetics influence drug effects
For neural tube defect, genetics influences decisions mostly around prevention and medicine use in pregnancy, rather than the surgical treatments after birth. Differences in genes that help the body use folate (a B vitamin) can affect how well someone responds to folic acid supplements, which are a key part of preventing neural tube defect. Genetics is only one factor, and most people still benefit from standard prenatal folic acid. If you’ve had a prior pregnancy affected or take certain medicines, doctors often recommend a higher dose of folic acid, about 4 mg (4,000 micrograms) daily before and during early pregnancy, regardless of genetic testing.
Some antiseizure drugs, especially valproate, raise the risk of neural tube defect; while genes can change how these medicines are broken down, this risk remains, so clinicians try to avoid or switch them when planning a pregnancy. Medicines that block folate, such as methotrexate, are avoided in pregnancy because they can cause harm, and genetic results do not make them safer. At this time, pharmacogenetic testing is not routinely used to guide the treatment of neural tube defect, but it may be considered as part of broader care planning when multiple medications are involved.
Interactions with other conditions
Living with a neural tube defect often brings other health issues into the picture, and these can interact in practical ways. Doctors call it a “comorbidity” when two conditions occur together. Many children with a neural tube defect such as spina bifida also have fluid build-up in the brain (hydrocephalus) or a hindbrain change (Chiari II), which can affect movement, breathing, or feeding and may require a shunt; shunt problems can, in turn, trigger headaches or infections. Bladder and bowel nerve changes are common and can lead to repeated urinary tract infections and, over time, kidney problems, while limited sensation and mobility can raise the risk of pressure sores and bone or joint issues like scoliosis or hip dislocation. People with a neural tube defect may also have epilepsy, vision or hearing differences, or a latex allergy, which can complicate hospital care and daily routines. Early symptoms of neural tube defect in a newborn can be overshadowed by these related problems, so teams often screen for urologic, orthopedic, and brain concerns from the start. Interactions can look very different from person to person, so coordinated care across neurology, urology, rehabilitation, and primary care helps tailor support as needs change.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with open backs or missing parts of the skull, long before anyone knew the term neural tube defect. Midwives and physicians recorded these findings in brief notes, parents passed down quiet stories, and communities adapted care as best they could. Some infants survived into childhood with weakness in the legs and bladder problems; others died soon after birth. The experiences varied widely, which made early understanding uneven.
First described in the medical literature as distinct birth anomalies, these conditions were initially grouped by appearance, not by a shared cause. Over time, descriptions became more precise: spina bifida for openings along the spine, anencephaly for severe underdevelopment of the brain and skull, and encephalocele for a sac-like bulge through the skull. Doctors noticed that certain regions and seasons seemed to have higher numbers. Families and communities once noticed patterns across generations, sparking early questions about heredity and nutrition.
By the mid-20th century, hospital records and birth registries helped map where neural tube defects were more common. In the 1960s–1980s, researchers linked folate (a B vitamin) levels before and during early pregnancy with risk. This shifted thinking from fate to prevention. Clinical trials in the late 1980s and early 1990s showed that folic acid supplements before conception and in the first trimester could lower the chance of neural tube defects. Many countries then fortified staple foods with folic acid, and rates fell, though not evenly everywhere.
As medical science evolved, ultrasound and maternal blood tests allowed earlier detection, often in the first or second trimester. Newborn care improved too. For babies with spina bifida, early surgery to close the spine reduced infections, and shunts helped treat fluid buildup in the brain. More recently, selected centers perform fetal surgery before birth to protect the exposed spinal cord, improving leg movement and reducing the need for shunts in some cases. These advances changed not only survival, but day-to-day outcomes for many living with spina bifida.
Genetics and epidemiology added more detail. We now know neural tube defects arise from a mix of factors—nutritional, genetic, and environmental—during the first month of pregnancy, often before someone knows they’re pregnant. Certain medicines, diabetes, obesity, and high fevers can raise risk, while folic acid lowers it. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Looking back helps explain why prevention is emphasized before pregnancy and why access to fortified foods and prenatal care matters. The history of neural tube defect care is one of gradual clarity: from scattered observations to targeted prevention, earlier diagnosis, and supportive treatments that continue to improve quality of life.